Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Avacta Sponsors 5th Annual Protein Formulation Development and Drug Delivery Forum

Published: Tuesday, June 03, 2014
Last Updated: Tuesday, June 03, 2014
Bookmark and Share
Company will showcase the capabilities of the Optim 2 instrument at the event.

Avacta Analytical has announced its sponsorship of this year’s Protein Formulation Development and Drug Delivery Forum in Barcelona, Spain.

Now in its fifth year, this exciting event runs from the 9th to the 11th of June, and will bring together research scientists from across the pharmaceutical and biotechnology sectors to explore current issues in protein formulation.

Protein formulation has become a highly important area of research for the pharmaceutical industry, and there is now increasing pressure to optimize drug formulations earlier in the development process to help avoid downstream failures and accelerate time-to-market.

This event will look at the latest innovations in protein formulation and drug delivery, highlighting recent research and technological advances - as well as updates to the regulatory framework - which can help to streamline and simplify formulation development activities.

Avacta will be showcasing the low volume protein characterization capabilities of the Optim 2 instrument at the event, giving delegates the opportunity to discuss how the system could help benefit their research with the Company’s technical experts.

Avacta’s Dr Geoff Platt will also be hosting a seminar entitled: ‘Strategy for stability assessment of antibodies: high throughput screening as a predictive tool for accelerating development’, providing practical examples of how novel technologies such as the Optim system can reduce the time and cost of therapeutic protein preformulation studies, protein stability testing and formulation development.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!